Cite
MLA Citation
M H Kulke et al.. “A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial.” Annals of oncology, vol. 30, 2019, p. 1846. http://access.bl.uk/ark:/81055/vdc_100099399783.0x00002f